Post-effective amendment to a registration statement that is not immediately effective upon filing

Share-based payments (Tables)

v3.22.2.2
Share-based payments (Tables)
 6 Months Ended 12 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Share Based Payments [Line Items]    
Summary of Input Parameters Discount for Lack of Marketability
Since the Part B fees include a
lock-up
mechanism, a discount for lack of marketability (“DLOM”) of 11.5% (December 31, 2021: 9.4%) has been applied using the following main input parameters:
 
Input parameters (DLOM)
   
March 17, 2022
    
December 31, 2021
  
Expected life
     
0.5
 
years		       
 0.5
 
years
 
Expected volatility
     
72.5
 %      58.6 % 
Expected dividend yield
     
0.0
 %      0.0 % 
Since
the Part B fees includes a
lock-up
mechanism, a discount for lack of marketability (“DLOM”) of
9.4
% (2020:
12.4
%—
23.5
%) has been applied under each of the possible scenarios using the following
main
input parameters:

Input parameters (DLOM)
  
2021
 
  
2020
 
Expected life
      0.5 years        0.5–3 years  
Expected volatility
      58.6%        74.1%–78.4%  
Expected dividend yield
      0.0%        0.0%  
Summary of Grant Options And Perfomance Options Granted Under The Plan
Set out below are summaries of Grant options and Performance Options granted under the plan:
 
 
  
For the six months ended June 30, 2022
 
  
Average exercise
price per share
option (in €)
 
  
Number
of grant

options
 
  
Number of
performance
options
 
As at January 1
   
 
—  
 
   
 
—  
 
   
 
—  
 
Granted during the period
      0.12        1,329,213        1,329,213  
Exercised during the period
      —          —          —  
Forfeited during the period
      —          —          —  
As at June 30
   
 
0.12
 
   
 
1,329,213
 
   
 
1,329,213
 
Vested and exercisable at June 30
      —          —          —    
 
Summary of Share options outstanding At The End Of The Reporting Period Following Expiry Dates And Exercise Prices
Share options outstanding at the end of the reporting period have the following expiry dates and exercise prices:
 
Options
   
Grant date
     
Expiry date
     
Exercise
price (in €)
     
Share options

June 30, 2022
  
Grant Options
      May 14, 2022        September 17, 2033        0.12        1,329,213  
Performance Options
      May 14, 2022        May 13, 2032        0.12        1,329,213  
Total
                              
 
2,658,426
 
Weighted average remaining contractual life of options outstanding at end of the reporting period
                                 11.1  
 
Second Special Fees Agreement [Member]    
Share Based Payments [Line Items]    
Summary of Input Parameters Discount for Lack of Marketability
The following main inputs parameters have been used to determine the present value of the expected payouts:
 
Input parameters (2
nd
SFA)
   
Value
  
Interest rate
      0.43 % 
Expected volatility
      60.0 % 
Expected dividend yield
      0.00 %